CG
BIB icon

Cutler Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Cutler Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-800
Closed -$6K – 2328
2023
Q4 		$6K Buy
+800
New +$37.5K ﹤0.01% 2621
2023
Q2 		– Sell
-1,500
Closed -$1K – 3579
2023
Q1 		$1K Sell
1,500
-1,300
-46% -$73.4K ﹤0.01% 3340
2022
Q4 		$2K Buy
2,800
+1,400
+100% +$78.8K ﹤0.01% 3628
2022
Q3 		$1K Buy
+1,400
New +$74.6K ﹤0.01% 4431
2022
Q2 		– Sell
-4,300
Closed -$9K – 4972
2022
Q1 		$9K Sell
4,300
-2,200
-34% -$135K ﹤0.01% 3670
2021
Q4 		$56K Buy
6,500
+2,700
+71% +$231K ﹤0.01% 2307
2021
Q3 		$14K Buy
3,800
+2,700
+245% +$273K ﹤0.01% 3634
2021
Q2 		$16K Buy
1,100
+600
+120% +$52.4K ﹤0.01% 3482
2021
Q1 		$1K Sell
500
-500
-50% -$47.2K ﹤0.01% 5134
2020
Q4 		$15K Buy
1,000
+800
+400% +$61.9K ﹤0.01% 2878
2020
Q3 		$3K Sell
200
-300
-60% -$21.3K ﹤0.01% 3780
2020
Q2 		$9K Sell
500
-4,700
-90% -$300K ﹤0.01% 2919
2020
Q1 		$3K Buy
5,200
+3,300
+174% +$184K ﹤0.01% 3283
2019
Q4 		$6K Buy
+1,900
New +$101K ﹤0.01% 2914
2019
Q3 		– Sell
-5,600
Closed -$4K – 4071
2019
Q2 		$4K Sell
5,600
-22,400
-80% -$1.11M ﹤0.01% 3183
2019
Q1 		$34K Buy
+28,000
New +$1.51M ﹤0.01% 1672
2018
Q2 		– Sell
-800
Closed -$1K – 4195
2018
Q1 		$1K Sell
800
-19,500
-96% -$1.17M ﹤0.01% 3972
2017
Q4 		$13K Sell
20,300
-42,500
-68% -$2.4M ﹤0.01% 2911
2017
Q3 		$310K Buy
62,800
+44,900
+251% +$2.55M 0.01% 906
2017
Q2 		$56K Buy
17,900
+15,200
+563% +$742K ﹤0.01% 2376
2017
Q1 		$8K Sell
2,700
-60,900
-96% -$2.83M ﹤0.01% 4233
2016
Q4 		$59K Buy
63,600
+44,600
+235% +$1.9M ﹤0.01% 2367
2016
Q3 		$86K Sell
19,000
-8,300
-30% -$394K ﹤0.01% 1934
2016
Q2 		$51K Sell
27,300
-11,900
-30% -$513K ﹤0.01% 2324
2016
Q1 		$72K Buy
39,200
+18,100
+86% +$800K ﹤0.01% 1935
2015
Q4 		$47K Buy
+21,100
New +$1.41M ﹤0.01% 2518

Other funds holding BIB

TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's BIB Position: Q3 2023 in Review

Cutler Group sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2023, closing a stake of 400 shares — an estimated $20.6K sold.

Cutler Group first reported a position in BIB in Q2 2016 and held it in 20 quarters. The position peaked at $94K in Q3 2021. 21 funds tracked by Wall St. Rank hold BIB as of Q3 2023.

  • Cutler Group reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 400 ProShares Ultra NASDAQ Biotechnology shares in Q3 2023, an estimated $20.6K.
  • Cutler Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2016 and held it in 20 quarters.
  • Cutler Group's ProShares Ultra NASDAQ Biotechnology position peaked at $94K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.